This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Resolution of the Nephrotic Syndrome With Melphalan and Prednisone

Robert A. Kyle, MD; Richard D. Wagoner, MD; Keith E. Holley, MD

Arch Intern Med. 1982;142(8):1445-1447.

Abstract
We describe two patients with primary systemic amyloidosis (AL) and the nephrotic syndrome. The administration of melphalan and prednisone was associated with resolution of the nephrotic syndrome. The serum albumin level returned to normal, proteinuria decreased to near normal, edema resolved, and the monoclonal protein in the serum and urine disappeared. In both patients, renal function remained stable and hepatomegaly disappeared. In both, however, amyloid deposition was greater in follow-up renal tissue than in the initial specimen. The effect of systemic therapy in AL must be assessed with histologic observations as well as clinical indexes.

(Arch Intern Med 1982;142:1445-1447)

Author Affiliations
From the Divisions of Hematology and Internal Medicine (Dr Kyle), and Nephrology and Internal Medicine (Dr Wagoner), and the Department of Anatomic Pathology (Dr Holley), Mayo Clinic and Mayo Foundation, Rochester, Minn.

Footnotes
Accepted for publication March 30, 1982.

Reprint requests to Mayo Clinic, Rochester, MN 55905 (Dr Kyle).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Amyloidosis-Associated Kidney Disease
Dember
J. Am. Soc. Nephrol. 2006;17:3458-3471.
ABSTRACT | FULL TEXT  

Amyloidosis and the lung
Lachmann and Hawkins
Chronic Respiratory Disease 2006;3:203-214.
ABSTRACT  

Recovery of acute renal failure and nephrotic syndrome following autologous stem cell transplantation for primary (AL) amyloidosis
Snanoudj et al.
Nephrol Dial Transplant 2003;18:2175-2177.
FULL TEXT  

Effect of Dose-Intensive Intravenous Melphalan and Autologous Blood Stem-Cell Transplantation on AL Amyloidosis-Associated Renal Disease
Dember et al.
ANN INTERN MED 2001;134:746-753.
ABSTRACT | FULL TEXT  

Kappa light chain-associated Fanconi's syndrome: molecular analysis of monoclonal immunoglobulin light chains from patients with and without intracellular crystals
Deret et al.
Protein Eng Des Sel 1999;12:363-369.
ABSTRACT | FULL TEXT  

Acute Leukemia and Cytogenetic Abnormalities Complicating Melphalan Treatment of Primary Systemic Amyloidosis
Gertz and Kyle
Arch Intern Med 1990;150:629-633.
ABSTRACT  

Subcutaneous Thoracentesis Utilizing an Ommaya Reservoir in Amyloid Cardiomyopathy
Mitnick et al.
JAMA 1986;255:1170-1171.
ABSTRACT  

Renal Amyloid Deposition and Nephrotic Syndrome
Conolly et al.
Arch Intern Med 1984;144:198-198.
ABSTRACT